Verified earnings results
Arbutus Biopharma Q2 2026 Earnings Results
Direct answer
Arbutus Biopharma reported Q2 2026 results on August 12, 2026.
Revenue was 1,014,000. EPS missed the estimate by 47.06%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Arbutus Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- August 12, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -0.0204
- Reported EPS
- -0.03
- Revenue
- 1,014,000
- EPS surprise
- EPS missed the estimate by 47.06%.
Explore related company data
Read the frequently asked questions.
When did Arbutus Biopharma report Q2 2026 earnings?
Arbutus Biopharma reported on August 12, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Arbutus Biopharma?
The verified record provides an EPS estimate of -0.0204.
Has Arbutus Biopharma reported the Q2 2026 result?
Revenue was 1,014,000. EPS missed the estimate by 47.06%.
Which source supports this Arbutus Biopharma earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.